Prognostic Significance of Radiographic Lymph Node I nvasion in Contemporary Metastatic Renal Cell Carcinoma Patients

被引:0
作者
Scheipner, Lukas [1 ,2 ,20 ]
Incesu, Reha-Baris [1 ,3 ]
Morra, Simone [1 ,4 ]
Baudo, Andrea [1 ,5 ]
Assad, Anis [1 ]
Jannello, Letizia Maria Ippolita [1 ,6 ,7 ]
Siech, Carolin [1 ,8 ]
de Angelis, Mario [1 ,9 ]
Tian, Zhe [1 ]
Saad, Fred [1 ]
Shariat, Shahrokh F. [10 ,11 ,12 ,13 ]
Briganti, Alberto
Chun, Felix K. H.
Tilki, Derya [14 ,15 ]
Longo, Nicola [1 ]
Carmignani, Luca [16 ]
De Cobelli, Ottavio [19 ]
Pichler, Martin [17 ,18 ]
Ahyai, Sascha [2 ]
Karakiewicz, Pierre I. [1 ]
机构
[1] Univ Montreal, Hlth Ctr, Div Urol, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
[2] Med Univ Graz, Dept Urol, Graz, Austria
[3] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[4] Univ Naples Federico II, Dept Neurosci Sci Reprod & Odontostomatol, Naples, Italy
[5] IRCCS Policlin San Donato, Dept Urol, Milan, Italy
[6] IEO European Inst Oncol, Dept Urol, Milan, Italy
[7] Univ Milan, Milan, Italy
[8] Goethe Univ Frankfurt Am Main, Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany
[9] IRCCS San Raffaele Sci Inst, Urol Res Inst, Div Expt Oncol, URI, Milan, Italy
[10] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
[11] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[12] Univ Texas Southwestern, Dept Urol, Dallas, TX USA
[13] AL Ahliyya Amman Univ, Hourani Ctr Appl Sci Res, Amman, Jordan
[14] Univ Hosp Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[15] Koc Univ Hosp, Dept Urol, Istanbul, Turkiye
[16] IRCCS Osped Galeazzi St Ambrogio, Dept Urol, Milan, Italy
[17] Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria
[18] Univ Augsburg, Med Fac, Dept Hematol & Oncol, Augsburg, Germany
[19] Univ Milan, Dept Oncol & Haemato Oncol, Milan, Italy
[20] Med Univ Graz, Dept Urol, Auenbruggerpl 1, A-8036 Graz, Austria
关键词
CSM; Population; -based; SEER; RCC; Prognosis; CYTOREDUCTIVE NEPHRECTOMY; TARGETED THERAPY; SURVIVAL; IMPACT;
D O I
10.1016/j.clgc.2023.10.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We tested for the prognostic significante of radiographic N-stage in metastatic renal cell carcinoma (mRCC) patients with low metastatic burden (single metastatic site). After multivariable adjustment, radiographic N1 status was an independent predictor of higher cancer-specific mortality (CSM). In consequence, consideration of radiographic lymph node invasion might be of great value in this specific population of mRCC patients. Purpose: To test the prognostic significance of radiographic cN-stage in metastatic renal cell carcinoma (mRCC) patients with low metastatic burden (1 site of metastasis), relying on the Surveillance, Epidemiology, and End Results database (SEER 2010-2020). Methods: Included were mRCC patients with 1 site of metastasis, treated with systemic therapy without cytoreductive nephrectomy (CN). Kaplan-Meier plots and multivariable Cox-regression models addressed cancer-specific mortality (CSM) according to radiographic cN-stage (ccN1 vs. ccN0). Separate subgroup analyses were performed, addressing radiographic N-stage in patients with distinct histology (clear-cell vs. RCC not otherwise specified [RCC NOS]). Results: Of 1756 mRCC patients, 545 (31%) were radiographic cN1. Overall, the median CSM-free survival of the cohort was 11 months. Median CSM-free survival was 8 vs. 14 months in radiographic cN1 vs. cN0 mRCC patients (HR 1.49, P < .0001). In multivariable Cox regression analyses, radiographic cN1 status was an independent predictor of higher CSM (HR 1.39; P = .01). In subgroup analyses, addressing patients with clear-cell histology and patients with RCC NOS separately, radiographic cN1 status remained independently associated with a higher CSM in both groups (clear-cell: HR 1.36; P = .03; RCC NOS: HR 2.06; P = .009). Conclusion: In mRCC patients with low metastatic burden, presence or absence of radiographic lymph node invasion results in a clinically meaningful discrimination between those with poor prognosis and others. In consequence, consideration of radiographic lymph node invasion might be of great value in this specific population of mRCC patients.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 14 条
[1]   The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study [J].
Andersson, Therese M-L ;
Myklebust, Tor Age ;
Rutherford, Mark J. ;
Moller, Bjorn ;
Soerjomataram, Isabelle ;
Arnold, Melina ;
Bray, Freddie ;
Parkin, D. Max ;
Sasieni, Peter ;
Bucher, Oliver ;
De, Prithwish ;
Engholm, Gerda ;
Gavin, Anna ;
Little, Alana ;
Porter, Geoff ;
Ramanakumar, Agnihotram, V ;
Saint-Jacques, Nathalie ;
Walsh, Paul M. ;
Woods, Ryan R. ;
Lambert, Paul C. .
CANCER EPIDEMIOLOGY, 2021, 71
[2]  
[Anonymous], Cause of death recode: SEER recodes
[3]  
[Anonymous], R Project for Statistical Computing (Version 3.0.2)
[4]   Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma [J].
Chakiryan, Nicholas H. ;
Gore, L. Robert ;
Reich, Richard R. ;
Dunn, Rodney L. ;
Jiang, Da David ;
Gillis, Kyle A. ;
Green, Elizabeth ;
Hajiran, Ali ;
Hugar, Lee ;
Zemp, Logan ;
Zhang, Jingsong ;
Jain, Rohit K. ;
Chahoud, Jad ;
Spiess, Philippe E. ;
Manley, Brandon J. ;
Sexton, Wade J. ;
Hollenbeck, Brent K. ;
Gilbert, Scott M. .
JAMA NETWORK OPEN, 2022, 5 (05)
[5]   Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era [J].
Conti, Simon L. ;
Thomas, I-Chun ;
Hagedorn, Judith C. ;
Chung, Benjamin I. ;
Chertow, Glenn M. ;
Wagner, Todd H. ;
Brooks, James D. ;
Srinivas, Sandy ;
Leppert, John T. .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) :2245-2252
[6]   Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma [J].
Han, KR ;
Pantuck, AJ ;
Bui, MHT ;
Shvarts, O ;
Freitas, DG ;
Zisman, A ;
Leibovich, BC ;
Dorey, FJ ;
Gitlitz, BJ ;
Figlin, RA ;
Belldegrun, AS .
UROLOGY, 2003, 61 (02) :314-319
[7]   Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma [J].
Iacovelli, Roberto ;
Lanoy, Emilie ;
Albiges, Laurence ;
Escudier, Bernard .
BJU INTERNATIONAL, 2012, 110 (11) :1747-1753
[8]   Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies [J].
Kroeger, Nils ;
Pantuck, Allan J. ;
Wells, J. Connor ;
Lawrence, Nicola ;
Broom, Reuben ;
Kim, Jenny J. ;
Srinivas, Sandy ;
Yim, Jessica ;
Bjarnason, Georg A. ;
Templeton, Arnoud ;
Knox, Jennifer ;
Bernstein, Ezra ;
Smoragiewicz, Martin ;
Lee, Jae ;
Rini, Brian I. ;
Vaishampayan, Ulka N. ;
Woodm, Lori A. ;
Beuselinck, Benoit ;
Donskov, Frede ;
Choueiri, Toni K. ;
Heng, Daniel Y. .
EUROPEAN UROLOGY, 2015, 68 (03) :506-515
[9]   Prognostic Significance of Lymph Node Invasion in Patients With Metastatic Renal Cell Carcinoma A Population-Based Perspective [J].
Lughezzani, Giovanni ;
Capitanio, Umberto ;
Jeldres, Claudio ;
Isbarn, Hendrik ;
Shariat, Shahrokh F. ;
Arjane, Philippe ;
Widmer, Hugues ;
Perrotte, Paul ;
Montorsi, Francesco ;
Karakiewicz, Pierre I. .
CANCER, 2009, 115 (24) :5680-5687
[10]   The Impact of Targeted Therapy on Management of Metastatic Renal Cell Carcinoma: Trends in Systemic Therapy and Cytoreductive Nephrectomy Utilization [J].
Psutka, Sarah P. ;
Kim, Simon P. ;
Gross, Cary P. ;
Van Houten, Holly ;
Thompson, R. Houston ;
Abouassaly, Robert ;
Weight, Christopher ;
Boorjian, Stephen A. ;
Leibovich, Bradley C. ;
Shah, Nilay D. .
UROLOGY, 2015, 85 (02) :442-450